Walker G L
Aust N Z J Med. 1979 Apr;9(2):184-7. doi: 10.1111/j.1445-5994.1979.tb04326.x.
A case is presented of a 64-year-old male with chronic inflammatory polyradiculoneuropathy (CIP) relentlessly progressing (despite steroids) to virtually complete quadriplegia over seven months. Once commenced on Azathioprine he dramatically improved over a six week period. The truly progressive form of CIP is rare. It is, however, immunologically similar to relapsing CIP and to the more common acute inflammatory polyradiculoneuropathy (AIP). Although the place of steroid therapy is still in doubt it would seem that cytotoxic immunosuppressives have something definite to offer in these conditions where there is progression beyond 4-5 weeks. In the largest series of CIP available (where the patients were untreated, or treated with steroids alone) the mortality rate was 11%, and the "complete recovery" rate only 5%. Although only isolated case reports are available, it would seem that if more aggressive immunosuppressive therapy was used more frequently, the prognosis might be considerably improved.
本文报告一例64岁男性慢性炎症性多发性神经根神经病(CIP)患者,尽管使用了类固醇药物,但病情仍在7个月内无情进展,几乎发展为完全性四肢瘫痪。开始使用硫唑嘌呤后,他在六周内显著改善。真正进行性的CIP形式很少见。然而,它在免疫学上与复发性CIP以及更常见的急性炎症性多发性神经根神经病(AIP)相似。尽管类固醇治疗的作用仍存在疑问,但在病情进展超过4-5周的情况下,细胞毒性免疫抑制剂似乎确实能发挥作用。在最大规模的CIP系列研究中(患者未接受治疗或仅接受类固醇治疗),死亡率为11%,“完全恢复”率仅为5%。尽管仅有个别病例报告,但似乎如果更频繁地使用更积极的免疫抑制治疗,预后可能会得到显著改善。